Comorbidity of 5,10-methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms and risk for neural tube defects

J Med Genet. 2000 Dec;37(12):949-51. doi: 10.1136/jmg.37.12.949.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 5,10-Methylenetetrahydrofolate Reductase (FADH2)
  • 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / genetics*
  • 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / metabolism
  • Comorbidity
  • Genetic Predisposition to Disease / epidemiology
  • Genetic Predisposition to Disease / genetics
  • Genetic Predisposition to Disease / prevention & control
  • Humans
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Neural Tube Defects / enzymology
  • Neural Tube Defects / epidemiology*
  • Neural Tube Defects / genetics*
  • Neural Tube Defects / prevention & control
  • Oxidoreductases / genetics*
  • Oxidoreductases / metabolism
  • Polymorphism, Genetic / genetics*
  • Risk Factors

Substances

  • Oxidoreductases
  • 5,10-Methylenetetrahydrofolate Reductase (FADH2)
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase